2013
Minimally invasive fibrillating mitral valve replacement for patients with advanced cardiomyopathy: A safe and effective approach to treat a complex problem
Brittain EL, Goyal SK, Sample MA, Leacche M, Absi TS, Papa F, Churchwell KB, Ball S, Byrne JG, Maltais S, Petracek MR, Mendes L. Minimally invasive fibrillating mitral valve replacement for patients with advanced cardiomyopathy: A safe and effective approach to treat a complex problem. Journal Of Thoracic And Cardiovascular Surgery 2013, 148: 2045-2051.e1. PMID: 24332110, PMCID: PMC4050032, DOI: 10.1016/j.jtcvs.2013.10.062.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiomyopathiesDisease-Free SurvivalFemaleHeart Valve Prosthesis ImplantationHospital MortalityHumansKaplan-Meier EstimateMaleMiddle AgedMinimally Invasive Surgical ProceduresMitral ValveMitral Valve InsufficiencyPostoperative ComplicationsRecurrenceRisk FactorsSeverity of Illness IndexStroke VolumeTime FactorsTreatment OutcomeVentricular Dysfunction, LeftVentricular Function, LeftVentricular Function, RightVentricular PressureVentricular RemodelingConceptsLV ejection fractionRecurrent mitral regurgitationRight ventricular systolic pressureVentricular systolic pressureMitral valve replacementSevere mitral regurgitationMitral regurgitationAdvanced cardiomyopathyValve replacementSystolic pressureLV dimensionsThoracic surgeonsNew York Heart Association classLV end-diastolic diameterComposite of deathEnd-diastolic diameterFirst postoperative visitOperative mortalityPostoperative morbidityPostoperative visitAssociation classClinical outcomesEjection fractionDevice insertionPatients
2007
Myocardial perfusion and function: Single photon emission computed tomography
Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, Cooke CD, Corbett JR, Cullom SJ, Dahlberg ST, Druz RS, Ficaro EP, Galt JR, Garg RK, Germano G, Heller GV, Henzlova MJ, Hyun MC, Johnson LL, Mann A, McCallister BD, Quaife RA, Ruddy TD, Sundaram SN, Taillefer R, Ward RP, Mahmarian JJ. Myocardial perfusion and function: Single photon emission computed tomography. Journal Of Nuclear Cardiology 2007, 14: e39-e60. PMID: 18022099, DOI: 10.1016/j.nuclcard.2007.09.023.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2006
Myocardial perfusion and function single photon emission computed tomography
Hansen CL, Goldstein RA, Berman DS, Churchwell KB, Cooke CD, Corbett JR, Cullom SJ, Dahlberg ST, Galt JR, Garg RK, Heller GV, Hyun MC, Johnson LL, Mann A, McCallister B, Taillefer R, Ward R, Mahmarian J. Myocardial perfusion and function single photon emission computed tomography. Journal Of Nuclear Cardiology 2006, 13: e97-e120. PMID: 17174800, DOI: 10.1016/j.nuclcard.2006.08.008.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsHumansQuality Assurance, Health CareRadiopharmaceuticalsTomography, Emission-Computed, Single-PhotonUnited StatesVentricular Dysfunction, Left
2005
Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
Stankewicz MA, Mansour CS, Eisner RL, Churchwell KB, Williams BR, Sigman SR, Streeter J, Patterson RE. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch. Journal Of Nuclear Medicine 2005, 46: 1602-9. PMID: 16204709.Peer-Reviewed Original ResearchConceptsMyocardial viabilityLeft ventriclePresence of severityEvidence of viabilityMyocardial viability assessmentNegative predictive valueViable myocardial tissueSurgical revascularizationCoronary diseaseClinical indicationsMetabolic assessmentSeverity criteriaAssessment of viabilityPET imagesPredictive valueWashout criteriaPatientsFDGQuantitative severityMyocardial tissuePositive criteriaGold standardWashoutSmall restingSeverity